Symyx Technologies — Merger or Acquisition (May 2010)
22 slides from Symyx Technologies's merger presentation, May 11, 2010
Slide 1: Accelrys, Inc. Investor Presentation May 2010
Accelrys, Inc. Investor Presentation May 2010 Max Carnecchia, CEO Michael Piraino, CFO
Slide 2: Safe Harbor Information
Safe Harbor Information Safe Harbor Provisions When used in this presentation, words such as expects, believes, anticipates, estimates, and similar expressions identify forward- looking statements. Forward-looking statements may include statements relating to our growth strategy, the future size of
Slide 3: Investment Summary
Investment Summary • Creates the leading enterprise scientific informatics software company • Provides the unparalleled capability of managing end-to-end scientific workflows to achieve better outcomes • Deep expertise in chemistry, biology and materials science creates a sustainable competitive adv
Slide 4: Market Environment
Market Environment
Slide 5: Scientific R&D Challenges Balance Innovation, Automation, Collaboration
Scientific R&D Challenges Balance Innovation, Automation, Collaboration Scientific innovation is not the only route to higher R&D productivity. Attention to the familiar management areas of cost, speed, and decision making can still reap rewards. Eric David, Tony Tramontin, and Rodney Zemmel McKinse
Slide 6: Today's Research & Development Challenge
Today’s Research & Development Challenge Drive Top Line Growth Drive Increased Profitability More Innovation • Increase R&D Success Rate – Re-Use Corporate Knowledge – Improve Data Modeling and Simulations – Increase Time Available for Experiments Better Productivity • Increase R&D Efficiency – Redu
Slide 7: Merger with Symyx
Merger with Symyx
Slide 8: Combining Industry Leaders
Combining Industry Leaders Founded: Public: ACCL (NASDAQ) FY Revenue: $80.9M Leading positions in: Data Collection and Analysis Data Access, Integration & Transformation Scientific Modeling and Simulation Workflow Automation and Optimization Employees: Headquarters: San Diego, CA Operations: NA, EME
Slide 9: Industry Leading Scientific Informatics Platform
Industry Leading Scientific Informatics Platform Decision Support Analytics Workflow Automation Reporting, Visualization & Collaboration Scientific Information Management Scientific Desktop Scientists R&D Manager VP of R&D Head of IT & Informatics Chemistry Engineering Biology Modeling & Sim Materia
Slide 10: With Global Brand Customer Portfolio and Minimal Product Overlap
With Global Brand Customer Portfolio and Minimal Product Overlap Accelrys + Symyx has over 1,350 total, unique customers including • 29 of the top 30 biopharmaceutical companies • 5 of the top 5 chemical companies • 5 of the top 5 aerospace companies • 3 of the top 5 CPG companies • And major Govern
Slide 11: Vibrant & Growing Partner Ecosystem
Vibrant & Growing Partner Ecosystem Electronic Lab Notebook Scientific Information Management Decision Support And Analytics Workflow Automation Reporting, Visualization And Collaboration Scientific Informatics Software System Additional applications and solutions developed by partner community More
Slide 12: Revenue Growth Drivers
Revenue Growth Drivers
Slide 13: Revenue Growth Drivers
Revenue Growth Drivers • New scientific markets • Biology/BioReg • Scientific Informatics Platform - Pipeline Pilot 8.0 • ELN – Symyx Notebook 6.4 • Professional Services
Slide 14: Pipeline Pilot
Pipeline Pilot • Enterprise Scientific Data Pipelining Platform • Data collection and Integration • Analysis • Visualization • Application Deployment • Capabilities • Integration of diverse data and applications • Automated scientific data analysis and processing • Capture and deployment of best-pra
Slide 15: 2010 Symyx Market Position by Domain
ELN/ELE No. 1 Market Position No. 2 or 3 Market Position DMPK* Market Position 2010 Symyx Market Position by Domain INTRODUCTION GROWTH MATURITY 50% Product Life Cycle Stage DMPK* Formulations Bioanalytical Pharmacology Process Chemistry Synthetic Chemistry *Addressed through partnership with Symyx
Slide 16: Deal Terms & Financials
Deal Terms & Financials
Slide 17: Terms of Deal
Terms of Deal Merger Agreement Closing Exchange Ratio Ownership Market Capitalization Cash Position Approvals Expected Synergies HQ Employees Leadership Board Membership Tax-free, all stock merger of equals Expected to close early in September quarter 0.7802 Each company’s stockholders will own appr
Slide 18: Proforma Balance Sheet December 31, 2009
Proforma Balance Sheet December 31, 2009 ($ in thousands) $152 Million in Cash and No Debt See Notes to Unaudited Pro Forma Condensed Combined Financial Statements Current Assets Cash & cash equivalents 133,841 $ Marketable securities 11,607 Restricted cash Trade receivables 38,972 Other current ass
Slide 19: Proforma Income Statement – Pre Synergies
Proforma Income Statement – Pre Synergies 9 Months Ended December 31, 2009 ($ in thousands) Annualized Revenue of ~ $170 million Geographic Split: NA-50%; EMEA-30%; APAC-20% See Notes to Unaudited Pro Forma Condensed Combined Financial Statements Accelrys Symyx Pro Forma Adjustments Pro Forma Combin
Slide 20: Key Dates
Key Dates SMMX Q1 earnings release Filing of joint proxy statement HSR clearance ACCL Board Meeting ACCL Q4/YE earnings release SEC clearance Shareholder’s Meetings (ACCL & SMMX) Closing ~5/12 5/18-19 ~6/5 Event Expected Timeline Continuous Integration Planning Activities
Slide 21: Focused Tactical Plan
Focused Tactical Plan From May 10, 2010
Slide 22: Accelrys, Inc. Forward-Looking Statements
Accelrys, Inc. Investor Presentation May 2010 Max Carnecchia, CEO Michael Piraino, CFO Forward-Looking Statements Certain statements in this communication may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements relate to
Symyx Technologies — Merger or Acquisition (May 2010) on 6ix